Causes of dysregulation of lipid metabolism in chronic renal failure.
about
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinAssessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney diseaseDialysis Procedures Alter Metabolic Conditions.Role of SN1 lipases on plasma lipids in metabolic syndrome and obesityAmelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysisDiscordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseImpaired postprandial lipemic response in chronic kidney disease.Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients.Unusual Dyslipidemia in Patients with Chronic Kidney Diseases.Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease.High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.Pleiotropic effects of niacin: Current possibilities for its clinical use.Dyslipidemia after pediatric renal transplantation-The impact of immunosuppressive regimens.High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.High-density lipoprotein particle pattern and overall lipid responses to a short-term moderate-intensity aerobic exercise training intervention in patients with chronic kidney disease.Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease.
P2860
Q28083619-7493D018-831C-4378-AE99-02B956B9B09AQ33591146-9A7A630E-6E67-497B-81FA-B5A20B3B6D9DQ33851814-6F1584B1-0587-4ADA-B0E8-35A6D88A153AQ33925409-DD50F749-6340-47DC-83C8-8EEB0948670FQ34308238-D64F4432-1940-410C-9B50-C0B66ACB1FCBQ35030586-DB9DA75F-C858-4EA6-B609-64C933C2D952Q36321501-4849C668-7C55-40AB-BA5C-AAC4BF6E570BQ36788430-C62A3C6C-971B-4510-BA63-AB122D0B2FF5Q37017211-48C8556F-F88E-4CBD-B976-A5A5A26F72DCQ37360393-8727BFD6-1DA1-47FA-8E9C-6215BF8F7DA7Q37663597-E6FDD267-C280-47E0-B9F8-C38420EC4D87Q37864183-C4AE6FE6-112B-4DF5-999E-7A82FCCEA7ACQ38084913-48B7131C-42BF-4781-88C1-84178F16972BQ38646836-43E6E273-826C-472E-9F9C-FCEEA7EF262CQ38810790-49AE90AC-977E-4A25-ADF0-D0212EA3D3AFQ38859167-3EDB0C7A-9A5C-4FB0-89A8-CC0C2939F86CQ40625511-027AE8E3-D833-4B38-B503-FDB6DA4A5648Q41511008-08EF01DA-1EDD-4E08-B2E5-E39B38DD79ADQ41908048-12605AA9-ECBE-4090-8D30-6A18EAF29018Q41980428-88C7AF75-B163-4711-8248-93D917A5DC7DQ43247391-D4D14522-B6B8-40FD-BFBC-CD088E76A732Q45145247-8B04B2A6-A9AA-4680-8F00-38A18DEC2A93Q46301471-08A74F54-63E7-42E5-9C82-D979FC1640F2Q51052574-CC853523-FB40-4A94-8D6B-BA62D0180F85
P2860
Causes of dysregulation of lipid metabolism in chronic renal failure.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Causes of dysregulation of lipid metabolism in chronic renal failure.
@en
Causes of dysregulation of lipid metabolism in chronic renal failure.
@nl
type
label
Causes of dysregulation of lipid metabolism in chronic renal failure.
@en
Causes of dysregulation of lipid metabolism in chronic renal failure.
@nl
prefLabel
Causes of dysregulation of lipid metabolism in chronic renal failure.
@en
Causes of dysregulation of lipid metabolism in chronic renal failure.
@nl
P2860
P1433
P1476
Causes of dysregulation of lipid metabolism in chronic renal failure.
@en
P2093
Nosratola D Vaziri
P2860
P304
P356
10.1111/J.1525-139X.2009.00661.X
P577
2009-11-01T00:00:00Z